Moreover, the levels of α-synuclein, phosphorylated Tyr-181 tau, and phosphorylated insulin receptor substrate-1 in neuronal L1CAM-immunocaptured EVs extracted from plasma of PD patients emerge as valuable biomarkers for predicting cognitive outcomes [83]. This evidence concerns the gene MAPT and Parkinson disease.